Becton Dickinson (NYSE:BDX) is in talks with rivals including Thermo Fisher (TMO) and Danaher (DHR) over plans to divest its ...

U.S. medical device maker Becton Dickinson is in talks with Thermo Fisher and Danaher for a potential sale of its life sciences unit, the Financial Times reported on Tuesday. Becton Dickinson had in ...

Buy rating initiated! Discover why this medtech leader with strong growth prospects & dividends is worth your attention.

River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 ...

Plus, an all-cash takeover offer for Fortnox surprises short sellers and a creditor-on-creditor fight makes its way to Europe ...

Of the 30 companies, three saw their stock prices increase, 26 saw their share prices decline, and one company's share price remained virtually flat month over month.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment ...

Shares of Becton Dickinson & Co. BDX rose 1.43% to $225.98 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 2.13% to 5,638. ...

Becton Dickinson (BDX) announced the first patient treated in an investigational device exemption clinical trial intended to advance BD’s ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's ...

Becton, Dickinson and Company stock opened at $227.95 on Tuesday. The firm has a market capitalization of $65.45 billion, a P/E ratio of 37.87, a P/E/G ratio of 1.63 and a beta of 0.35. The ...